Westone Audio has been acquired by Lucid Audio
Westone Laboratories, Inc., a portfolio company of HealthEdge Partners, has sold its premium in-ear monitor business Westone Audio to Lucid Audio, LLC, a wholly owned subsidiary of Hearing Lab Technology.
Westone Audio is a leading designer, manufacturer and distributor of universal and custom-fit premium wired earphones for recreational listeners and musicians. The company pioneered the custom in-ear monitor market in the 1980s and its products deliver industry-leading sound precision, ergonomics, fit and hearing preservation. Their custom and universal fit earphones cater to passionate audiophiles worldwide.
Lucid Audio is a manufacturer and provider of a variety of audio products which span the range from infant and child protective HearMuffs with advanced comfort and control features, to AMPED® wireless audio devices with quality amplification of inside and outside sounds, to personal sound amplification products that make hearing better accessible to everyone.
Oaklins’ team in Los Angeles acted as the exclusive financial advisor to Westone Laboratories in this transaction.
Talk to the deal team
Gary S. Rabishaw
Managing DirectorLos Angeles, United States
Associate DirectorLos Angeles, United States
Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)
Private equity firm 3i Group and the private shareholders of Permali Gloucester Limited have sold their interest in the company to Diamorph.Learn more
Kirkenes Fondsforvaltning has sold a minority stake in Baltic Pork to Mork Engebretsen Invest
Kirkenes Fondsforvaltning, a Norwegian state-backed CEE investment fund, has sold a minority stake in Baltic Pork LLC, one of the largest Latvian pig farming businesses, to Mork Engebretsen Invest, a Norwegian private investor.Learn more
BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.Learn more